Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt
Open Access
- 1 January 2013
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 5 (1), 38-42
- https://doi.org/10.4254/wjh.v5.i1.38
Abstract
To evaluate long-term complications and survival in patients with Budd-Chiari syndrome (BCS) referred to a Danish transjugular intrahepatic portosystemic shunt (TIPS) centre.Twenty-one consecutive patients from 1997-2008 were retrospectively included [15 women and 6 men, median age 40 years (range 17-66 years)]. Eighteen Danish patients came from the 1.8 million catchment population of Aarhus University Hospital and three patients were referred from Scandinavian hospitals. Management consisted of tests for underlying haematological, endocrinological, or hypercoagulative disorders parallel to initiation of specific treatment of BCS.BCS was mainly caused by thrombophilic (33%) or myeloproliferative (19%) disorders. Forty-three percents had symptoms for less than one week with ascites as the most prevalent finding. Fourteen (67%) were treated with TIPS and 7 (33%) were manageable with treatment of the underlying condition and diuretics. The median follow-up time for the TIPS-treated patients was 50 mo (range 15-117 mo), and none required subsequent liver transplantation. Ascites control was achieved in all TIPS patients with a marked reduction in the dose of diuretics. A total of 14 TIPS revisions were needed, mostly of uncovered stents. Two died during follow-up: One non-TIPS patient worsened after 6 mo and died in relation to transplantation, and one TIPS patient died 4 years after the TIPS-procedure, unrelated to BCS.In our BCS cohort TIPS-treated patients have near-complete survival, reduced need for diuretics and compared to historical data a reduced need for liver transplantation.Keywords
This publication has 31 references indexed in Scilit:
- Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shuntBMC Gastroenterology, 2010
- Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndromeGut, 2008
- Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysisLiver Transplantation, 2007
- Corrigendum to “Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension” [J Hepatol 43 (2005) 167–176]Journal of Hepatology, 2005
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005
- TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experienceJournal of Hepatology, 2003
- Budd–Chiari syndrome: a review by an expert panelJournal of Hepatology, 2003
- Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factorsHepatology, 2000
- Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shuntingHepatology, 1999
- Proposal of a new nomenclature for budd-chiari syndrome: Hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portionHepatology, 1998